Revenue | ₹0.05Cr |
Net Profits | ₹0.39Cr |
Net Profit Margins | -780.00% |
Transgene Biotek Ltd’s revenue fell -50% since last year same period to ₹0.05Cr in the Q2 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 0% jump in its revenue since last 3-months.
Transgene Biotek Ltd’s net profit fell -457.14% since last year same period to ₹0.39Cr in the Q2 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 9.3% jump in its net profits since last 3-months.
Transgene Biotek Ltd’s net profit margin fell -1014.29% since last year same period to -780.00% in the Q2 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 9.3% jumped in its net profit margins since last 3-months.
The revenue for Transgene Biotek Ltd in the Q2 results 2025 was ₹0.05Cr.
The net profit for Transgene Biotek Ltd in the Q2 results 2025 was ₹0.39Cr.
The net profit margin for Transgene Biotek Ltd in the Q2 results 2025 was -780.00%.
The revenue for Transgene Biotek Ltd in the Q2 results 2024 was ₹0.10Cr.
The net profit for Transgene Biotek Ltd in the Q2 results 2024 was ₹0.07Cr.
The net profit margin for Transgene Biotek Ltd in the Q2 results 2024 was -70.00%.